Practice Guidelines

ACIP Releases 2016 Childhood Immunization Recommendations


FREE PREVIEW. AAFP members and paid subscribers: Log in to get free access. All others: Purchase online access.

FREE PREVIEW. Purchase online access to read the full version of this article.

Am Fam Physician. 2016 Feb 15;93(4):317-322.

Author disclosure: No relevant financial affiliations.

Key Points for Practice

• Children with a history of sexual assault should be vaccinated against HPV starting at nine years of age.

• Persons 16 to 23 years of age may be vaccinated to provide short-term protection against most strains of meningococcal B disease.

• There is no contraindication to giving the meningococcal B and quadrivalent meningococcal conjugate vaccines on the same day as long as different administration sites are used.

• Unlike the HPV vaccine series, which may be completed with any available vaccine preparation, meningococcal vaccines are not interchangeable.

From the AFP Editors

Each year, the Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease Control and Prevention reviews and updates the childhood immunization schedule to incorporate any published updates or corrections from the previous year. The 2016 childhood immunization schedule is available at

In addition to updated references, the childhood schedule has been reconfigured to list vaccinations from earliest to latest age of first recommended administration. This

editor's note: The author serves as liaison to ACIP for the AAFP.

Address correspondence to Margot Savoy, MD, MPH, at Reprints are not available from the author.


1. Petrosky E, Bocchini JA Jr, Hariri S, et al.; Centers for Disease Control and Prevention. Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep. 2015;64(11):300–304. Accessed October 22, 2015.

2. Folaranmi T, Rubin L, Martin SW, Patel M, MacNeil JR; Centers for Disease Control and Prevention. Use of serogroup B meningococcal vaccines in persons aged ≥ 10 years at increased risk for serogroup B meningococcal disease: recommendations of the Advisory Committee on Immunization Practices, 2015 [published correction appears in MMWR Morb Mortal Wkly Rep. 2015;64(29):806]. MMWR Morb Mortal Wkly Rep. 2015;64(22):608–12. Accessed October 22, 2015.

Coverage of guidelines from other organizations does not imply endorsement by AFP or the AAFP.

This series is coordinated by Sumi Sexton, MD, Associate Deputy Editor.

A collection of Practice Guidelines published in AFP is available at


Copyright © 2016 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact for copyright questions and/or permission requests.

Want to use this article elsewhere? Get Permissions

CME Quiz

More in AFP

More in Pubmed


Oct 15, 2016

Access the latest issue of American Family Physician

Read the Issue

Email Alerts

Don't miss a single issue. Sign up for the free AFP email table of contents.

Sign Up Now

Navigate this Article